|
|
 |
|
Viewing report
|
|
|
|
Central Nervous System - Memory Impairment
Life Science Analytics, March 2008, Pages: 65
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company’s full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company’s strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company’s research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
Customers who bought this item also bought
The Neurotechnology Industry 2011 Report
The Central Nervous Systems Market 2010 Report
Alzheimer Disease - New Drugs, Markets and Companies
Oncology Market Forecast to 2015: Brand Spending and Development Opportunities
Bipolar Disorder - Global Strategic Business Report
Innovations in Protein Kinase Therapies - Significant Proportion of Protein Kinase Pipeline Contains Small Molecule Drugs That Target Oncology
Neurodegenerative Drugs - Global Strategic Business Report
Autoimmune And Inflammation Rheumatoid Arthritis
Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players
Competitor Analysis - Cancer Antibodies in Early Clinical Development
|
|
|
|
